This case report describes a 36-year-old woman who was pregnant for the fourth time when she was diagnosed with an insulinoma. The medical team used a multidisciplinary approach to manage her condition. They started with medical therapy using octreotide and later performed endoscopic ultrasound-guided radiofrequency ablation. This procedure involved two sessions to treat the tumor. The team also considered the safety of the pregnancy throughout the treatment process.
The results showed that the patient achieved partial control of her blood sugar levels while using octreotide. After the two sessions of radiofrequency ablation, her blood sugar levels stabilized. However, the pregnancy did not go to full term. The baby experienced growth restriction, which is a condition where the fetus does not grow at the expected rate. Delivery occurred at 34 weeks gestation.
The report highlights the importance of individualized management guided by a multidisciplinary team. It also points out the diagnostic challenges involved in treating insulinomas during pregnancy. The authors note that the limitations of current therapies, especially for larger tumors, are significant. Because this is a single case report, the findings cannot be generalized to all patients. More research is needed to understand the risks and benefits of these treatments in pregnancy.